Your browser doesn't support javascript.
loading
Long duration of immunotherapy in a STK11 mutated/KRAS wild-type non-small cell lung cancer patient.
Domingues, I; Cedres, S; Callejo, A; Vivancos, A; Martinez-Marti, A; Felip, E.
Affiliation
  • Domingues I; Medical Oncology Department, Portuguese Institute of Oncology of Coimbra, Coimbra, Portugal. Electronic address: isabelcpdomingues@gmail.com.
  • Cedres S; Medical Oncology Department, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Callejo A; Medical Oncology Department, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Vivancos A; Cancer Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Martinez-Marti A; Medical Oncology Department, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Felip E; Medical Oncology Department, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Pulmonology ; 26(1): 49-50, 2020.
Article in En | MEDLINE | ID: mdl-31401029
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: DNA, Neoplasm / Proto-Oncogene Proteins p21(ras) / Protein Serine-Threonine Kinases / Carcinoma, Non-Small-Cell Lung / Immunotherapy / Lung Neoplasms / Mutation Limits: Female / Humans / Middle aged Language: En Journal: Pulmonology Year: 2020 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: DNA, Neoplasm / Proto-Oncogene Proteins p21(ras) / Protein Serine-Threonine Kinases / Carcinoma, Non-Small-Cell Lung / Immunotherapy / Lung Neoplasms / Mutation Limits: Female / Humans / Middle aged Language: En Journal: Pulmonology Year: 2020 Document type: Article